Latest Device for In-Home Hair Restoration Technology Cleared by FDA
I am pleased to announce that the Capillus272™ low-level laser therapy device has been cleared by the Food and Drug Administration (FDA) for the treatment of androgenic alopecia (male and female pattern hair loss). Leonard Hair Transplant Associates is the only medical hair-loss practice to offer the Capillus272™ to patients in New England.
The Capillus272™ is an innovative, mobile, battery-operated laser product that fits discreetly into a baseball cap. Leonard Hair Transplant Associates has been exclusively offering this device in our Massachusetts, Rhode Island and New Hampshire offices for the past three years.
We are extremely excited that the US Food and Drug Administration has provided clearance of the Capillus272 laser device for the treatment of male and female pattern hair loss. Leonard Hair Transplant Associates has been a strong advocate of low-level laser therapy for more than 15 years.
With 272 lasers, the Capillus272™ emits more laser energy than any other low-level laser therapy product in the marketplace. Its FDA clearance is based on an independently reviewed clinical trial, and it’s indicated for the treatment in both men and women. It is lightweight and battery-powered and comfortably fits within a baseball cap for unnoticed, private use.
The Capillus272™ provides superlative results while patients use it in the comfort of their homes or on the go. The device is worn for only one half hour, every other day. Patients can expect to notice results after approximately four months of use; however, a final medical evaluation takes place after one year of use.
Dr. Robert Leonard